Geode Capital Management
AONC

Geode Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Geode Capital Management’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,687
Closed -$125K – 4652
2024
Q1 		$125K Buy
22,687
+629
+3% +$3.63K ﹤0.01% 4092
2023
Q4 		$127K Buy
22,058
+9,683
+78% +$62.8K ﹤0.01% 4102
2023
Q3 		$115K Sell
12,375
-764
-6% -$9.38K ﹤0.01% 4198
2023
Q2 		$136K Hold
13,139
– – ﹤0.01% 4219
2023
Q1 		$134K Hold
13,139
– – ﹤0.01% 4227
2022
Q4 		$131K Hold
13,139
– – ﹤0.01% 4292
2022
Q3 		$129K Buy
13,139
+2,247
+21% +$22.1K ﹤0.01% 4445
2022
Q2 		$106K Hold
10,892
– – ﹤0.01% 4569
2022
Q1 		$106K Buy
+10,892
New +$106K ﹤0.01% 4644

Other funds holding AONC

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's AONC Position: Q2 2024 in Review

Geode Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2024, closing a stake of 22,687 shares — an estimated $125K sold.

Geode Capital Management first reported a position in AONC in Q1 2022 and held it in 9 quarters. The position peaked at $136K in Q2 2023. 2 funds tracked by Wall St. Rank hold AONC as of Q2 2024.

  • Geode Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Geode Capital Management sold 22,687 American Oncology Network, Inc. Class A Common Stock shares in Q2 2024, an estimated $125K.
  • Geode Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 9 quarters.
  • Geode Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $136K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2024.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.